Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma.
Targeting oncogenic ALK and MET: a promising therapeutic strategy for glioblastoma. Metab Brain Dis. 2013 Sep; 28(3):355-66.
View in:
PubMed
subject areas
Animals
Brain Neoplasms
Glioblastoma
Humans
Protein Kinase Inhibitors
Proto-Oncogene Proteins c-akt
Proto-Oncogene Proteins c-met
Receptor Protein-Tyrosine Kinases
Signal Transduction
authors with profiles
William Alexander Vandergrift
Pierre Giglio
Sunil J. Patel
Arabinda Das
Swapan KUMAR Ray